Cargando…

miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2

Detalles Bibliográficos
Autores principales: Cao, Huiyan, Liu, Zhiming, Wang, Rong, Zhang, Xiaodong, Yi, Wenfa, Nie, Guanyuan, Yu, Yong, Wang, Guolu, Zhu, Mingting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773008/
https://www.ncbi.nlm.nih.gov/pubmed/36453255
http://dx.doi.org/10.3892/or.2022.8454
_version_ 1784855105138327552
author Cao, Huiyan
Liu, Zhiming
Wang, Rong
Zhang, Xiaodong
Yi, Wenfa
Nie, Guanyuan
Yu, Yong
Wang, Guolu
Zhu, Mingting
author_facet Cao, Huiyan
Liu, Zhiming
Wang, Rong
Zhang, Xiaodong
Yi, Wenfa
Nie, Guanyuan
Yu, Yong
Wang, Guolu
Zhu, Mingting
author_sort Cao, Huiyan
collection PubMed
description
format Online
Article
Text
id pubmed-9773008
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-97730082022-12-29 miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2 Cao, Huiyan Liu, Zhiming Wang, Rong Zhang, Xiaodong Yi, Wenfa Nie, Guanyuan Yu, Yong Wang, Guolu Zhu, Mingting Oncol Rep Retraction D.A. Spandidos 2022-11-28 /pmc/articles/PMC9773008/ /pubmed/36453255 http://dx.doi.org/10.3892/or.2022.8454 Text en Copyright: © Cao et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Retraction
Cao, Huiyan
Liu, Zhiming
Wang, Rong
Zhang, Xiaodong
Yi, Wenfa
Nie, Guanyuan
Yu, Yong
Wang, Guolu
Zhu, Mingting
miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2
title miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2
title_full miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2
title_fullStr miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2
title_full_unstemmed miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2
title_short miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2
title_sort mir-148a suppresses human renal cell carcinoma malignancy by targeting akt2
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773008/
https://www.ncbi.nlm.nih.gov/pubmed/36453255
http://dx.doi.org/10.3892/or.2022.8454
work_keys_str_mv AT caohuiyan mir148asuppresseshumanrenalcellcarcinomamalignancybytargetingakt2
AT liuzhiming mir148asuppresseshumanrenalcellcarcinomamalignancybytargetingakt2
AT wangrong mir148asuppresseshumanrenalcellcarcinomamalignancybytargetingakt2
AT zhangxiaodong mir148asuppresseshumanrenalcellcarcinomamalignancybytargetingakt2
AT yiwenfa mir148asuppresseshumanrenalcellcarcinomamalignancybytargetingakt2
AT nieguanyuan mir148asuppresseshumanrenalcellcarcinomamalignancybytargetingakt2
AT yuyong mir148asuppresseshumanrenalcellcarcinomamalignancybytargetingakt2
AT wangguolu mir148asuppresseshumanrenalcellcarcinomamalignancybytargetingakt2
AT zhumingting mir148asuppresseshumanrenalcellcarcinomamalignancybytargetingakt2